Observational studyClinical and experimental nephrology2025

Safety and efficacy of tolvaptan in real‑world Japanese patients with autosomal dominant polycystic kidney disease: final results of SLOW‑PKD surveillance.

Toshio Mochizuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.